Latest news

Insights

Top 10 Pharma News Websites You Should Follow in 2026

Executive Summary In 2026, pharma and biotech are evolving at unprecedented speed. AI-driven drug discovery, digital transformation, personalized medicine, and...
Insights

How Are Life Sciences Companies Raising Capital in 2026?

Executive Summary In 2026, raising capital in life sciences is no longer about access—it is about proof. The traditional reliance...
Research & Development

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Kailera Therapeutics has provided additional details regarding its planned initial public offering, aiming to raise up to $528.5 million...
Commercial

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

Artificial intelligence startup Keebler Health has secured $16 million in a Series A financing round aimed at supporting the...
Insights

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

Executive Summary AI can partially predict regulatory outcomes in pharma...
Insights

Market Access Challenges in Pharmaceuticals: Pricing, Policy, and Payer Pressure

Executive Summary Market access challenges in pharmaceuticals in 2026 are...
Insights

Why Is Market Access Becoming More Difficult for Pharma Companies?

Executive Summary Market access is becoming more difficult for pharma companies in 2026 due to a convergence of pricing pressure,...
Insights

Launch Readiness in Pharma: Overcoming Market Entry Barriers

Executive Summary Launch readiness in pharma in 2026 is defined by the ability to overcome market entry barriers across pricing,...
Insights

What Commercial Strategy Mistakes Do Biotech Companies Make?

Executive Summary Biotech companies in 2026 most commonly fail commercially not because of weak science, but due to avoidable strategy...
Insights

The Role of AI and Data in Driving Pharma Innovation

Executive Summary AI and data are now central to driving...
Insights

Innovation vs Regulation in Life Sciences: Can Companies Balance Both?

Innovation vs Regulation:Executive Summary Yes—life sciences companies can balance innovation...
Insights

Responding to Patent Expirations and Generic Competition

Executive Summary Patent expiration refers to the end of market exclusivity, after which generic or biosimilar competitors can enter. Pharma...
Clinical

Travere’s Filspari becomes the first FDA-approved medication for FSGS

Travere Therapeutics had a long and rocky road to take its drug Filspari to patients with focal segmental glomerulosclerosis...
Insights

How Pharma Companies Are Adapting to Market Disruption

Executive Summary Pharma companies are adapting to market disruption in 2026 by shifting from traditional, linear operating models to integrated,...
Commercial

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

Artificial intelligence startup Keebler Health has secured $16 million...
Editorial Team -
Commercial

R1 Therapeutics Announces Itself With $77.5M Series A Round to Tackle Kidney Disease

R1 Therapeutics has launched with an oversubscribed $77.5 million...
Commercial

Novartis strikes $1.1B deal with China’s Baiyu for a small molecule cancer contender

Novartis is investing over $70 million in Chengdu Baiyu...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Insights

How Are Life Sciences Companies Raising Capital in 2026?

Executive Summary In 2026, raising capital in life sciences is...
Research & Development

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Kailera Therapeutics has provided additional details regarding its planned...
Commercial

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

Artificial intelligence startup Keebler Health has secured $16 million...
Commercial

BMS and Bain Capital Launch Beeline Medicines with Autoimmune Pipeline Led by Afimetoran

A new biotechnology company, Beeline Medicines, has emerged from...

Research & Development

Market Access

Manufacturing

Lilly’s Plan to Build $3B Dutch Plant Underway, 500 Hires Also in the Pipeline

Eli Lilly Expands European Manufacturing with a $3 Billion...
Manufacturing

Alkermes plans to acquire Avadel and its long-acting narcolepsy medication Lumryz for $2.1 billion

Alkermes, which plans to spend up to $2.1 billion...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Pharma News Websites You Should Follow in 2026

Executive Summary In 2026, pharma and biotech are evolving at...
Editorial Team -
Manufacturing

UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

Belgium-based UCB has announced plans to invest $2 billion...
Editorial Team -